KR102034192B1 - Phenanthroline-triazine compound and organic light emitting diode comprising the same - Google Patents

Phenanthroline-triazine compound and organic light emitting diode comprising the same Download PDF

Info

Publication number
KR102034192B1
KR102034192B1 KR1020170149589A KR20170149589A KR102034192B1 KR 102034192 B1 KR102034192 B1 KR 102034192B1 KR 1020170149589 A KR1020170149589 A KR 1020170149589A KR 20170149589 A KR20170149589 A KR 20170149589A KR 102034192 B1 KR102034192 B1 KR 102034192B1
Authority
KR
South Korea
Prior art keywords
light emitting
layer
compound
charge generation
phenanthroline
Prior art date
Application number
KR1020170149589A
Other languages
Korean (ko)
Other versions
KR20190053562A (en
Inventor
김동현
이응
박도우
이상진
이지환
조은상
국창훈
김대환
황보선
Original Assignee
주식회사 진웅산업
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 진웅산업 filed Critical 주식회사 진웅산업
Priority to KR1020170149589A priority Critical patent/KR102034192B1/en
Publication of KR20190053562A publication Critical patent/KR20190053562A/en
Application granted granted Critical
Publication of KR102034192B1 publication Critical patent/KR102034192B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • H01L51/0067
    • H01L51/0071
    • H01L51/5012
    • H01L51/5048
    • H01L51/5088
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/17Carrier injection layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

본 발명은 페난트롤린-트리아진 화합물 및 이를 하나 이상의 유기층에 포함함으로써 우수한 효율 특성을 나타내는 유기전기발광소자에 관한 것이다.The present invention relates to an phenanthroline-triazine compound and an organic electroluminescent device exhibiting excellent efficiency characteristics by including it in at least one organic layer.

Description

페난트롤린-트리아진 화합물 및 이를 포함하는 유기발광소자 {PHENANTHROLINE-TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING THE SAME}PHENANTHROLINE-TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING THE SAME}

본 출원은 경기도경제과학진흥원에서 주관하는 2017년 글로벌강소기업 지역 자율 프로그램을 통해 일부 출원비 지원을 받아 진행되었음을 밝힙니다.
본 발명은 페난트롤린-트리아진 화합물 및 이를 포함하는 유기발광소자에 관한 것이다.
This application has been filed with some application fees through the 2017 Global Hidden Champions Autonomous Program hosted by the Gyeonggi-do Economic Research Institute.
The present invention relates to a phenanthroline-triazine compound and an organic light emitting device comprising the same.

유기발광소자는 유기 물질을 이용하여 전기 에너지를 빛 에너지로 전환하기 위한 소자로서, 제1전극과 제2전극 사이에 발광 가능한 유기물층이 형성된 구조를 포함한다. 유기발광소자는 다양한 구조로 형성될 수 있으며, 그 중 복수의 발광부가 적층된 탠덤(Tandem)형 유기발광소자가 연구되고 있다.The organic light emitting device is a device for converting electrical energy into light energy using an organic material, and includes an organic light emitting layer formed between the first electrode and the second electrode. The organic light emitting device may be formed in various structures, and among them, a tandem organic light emitting device in which a plurality of light emitting parts are stacked is being studied.

탠덤형 유기발광소자에서는 각 발광부들 사이에 전자와 정공이 생성될 수 있는 N형 전하생성층 및 P형 전하생성층으로 이루어져 있다. 대체로 N형 전하생성층과 P형 전하생성층 사이에서 전하가 생성되어 N형 전하생성층과 인접한 전자주입층으로 전자가 이동하고 P형 전하생성층과 인접한 정공주입층으로 정공이 전달된다. In the tandem organic light emitting device, an N-type charge generation layer and a P-type charge generation layer capable of generating electrons and holes between respective light emitting portions are formed. In general, charges are generated between the N-type charge generation layer and the P-type charge generation layer to transfer electrons to the electron injection layer adjacent to the N-type charge generation layer and to transfer holes to the hole injection layer adjacent to the P-type charge generation layer.

이 때, N형 전하생성층과 P형 전하생성층 사이의 에너지 레벨 차이가 클수록, 전자가 N형 전하생성층으로 주입되기 어려워진다. 또한, N형 전하생성층에 알칼리 금속이 도핑된 경우, 알칼리 금속이 P형 전하생성층등 인접층으로 확산되어 전류 누설이 발생할 수 있다. 이는 소자의 수명을 저하시킬 수 있다.At this time, the larger the energy level difference between the N-type charge generation layer and the P-type charge generation layer, the more difficult electrons are injected into the N-type charge generation layer. In addition, when the alkali metal is doped into the N-type charge generation layer, the alkali metal may diffuse into an adjacent layer such as a P-type charge generation layer and current leakage may occur. This may lower the life of the device.

한국특허공개 제10-2013-0059328호(2013년02월04일 공개)Korean Patent Publication No. 10-2013-0059328 (published 04 February 2013)

본 발명의 목적은 새로운 구조의 페난트롤린-트리아진 화합물을 제공하는 것이다.It is an object of the present invention to provide a phenanthroline-triazine compound of novel structure.

본 발명의 다른 목적은 탠덤형 유기발광소자에서 N형 전하생성층과 P형 전하생성층 사이의 에너지 레벨 차이를 최소화하여 발광부에 전자 주입량을 향상시킬 수 있는 페난트롤린-트리아진 화합물 및 이를 포함하는 유기발광소자를 제공하는 것이다.Another object of the present invention is to provide a phenanthroline-triazine compound which can improve the amount of electron injection in the light emitting part by minimizing the difference in energy level between the N-type charge generating layer and the P-type charge generating layer in a tandem organic light emitting diode and It is to provide an organic light emitting device comprising.

본 발명의 또 다른 목적은 N형 전하생성층이 알칼리 금속으로 도핑된 경우에도, 알칼리 금속이 P형 전하생성층으로 확산되는 현상을 최소화할 수 있는 페난트롤린-트리아진 화합물 및 이를 포함하는 유기발광소자를 제공하는 것이다.Still another object of the present invention is to provide a phenanthroline-triazine compound capable of minimizing the diffusion of alkali metal into the P-type charge generation layer, even when the N-type charge generation layer is doped with an alkali metal, and an organic compound including the same. It is to provide a light emitting device.

본 발명의 목적은 하기 화학식 1 또는 화학식 2로 표시되는 페난트롤린(phenanthroline)-트리아진(triazine) 화합물에 의해 달성된다.The object of the present invention is achieved by a phenanthroline-triazine compound represented by the following formula (1) or (2).

[화학식 1] [화학식 2][Formula 1] [Formula 2]

Figure 112017111791394-pat00001
Figure 112017111791394-pat00001

화학식 1 또는 2에서, X1, X2, X3 및 X4는 독립적으로 탄소 또는 질소이며, R1 내지 R7은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; -CN; 치환 또는 비치환된 C1 내지 C60의 직쇄 또는 분지쇄의 알킬기; 치환 또는 비치환된 C2 내지 C60의 직쇄 또는 분지쇄의 알케닐기; 치환 또는 비치환된 C2 내지 C60의 직쇄 또는 분지쇄의 알키닐기; 치환 또는 비치환된 C3 내지 C60의 단환 또는 다환의 시클로알킬기; 치환 또는 비치환된 C2 내지 C60의 단환 또는 다환의 헤테로시클로알킬기; 치환 또는 비치환된 C6 내지 C60의 단환 또는 다환의 아릴기; 치환 또는 비치환된 C2 내지 C60의 단환 또는 다환의 헤테로아릴기; -SiRR'R"; -P(=O)RR'; -S(=O)(=O)R 및 -NRR'으로 이루어진 군으로부터 선택되며, L은 생략되거나, 하기와 같은 치환 또는 비치환된 페닐렌; 또는 치환 또는 비치환된 바이페닐릴렌 중 선택되는 어느 하나이다.In Formula 1 or 2, X 1 , X 2 , X 3 and X 4 are independently carbon or nitrogen, R 1 to R 7 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Halogen group; -CN; A substituted or unsubstituted C1 to C60 straight or branched alkyl group; Substituted or unsubstituted C2 Through C60 A straight or branched chain alkenyl group; Substituted or unsubstituted C2 Through C60 A straight or branched chain alkynyl group; A substituted or unsubstituted C3 to C60 monocyclic or polycyclic cycloalkyl group; A substituted or unsubstituted C2 to C60 monocyclic or polycyclic heterocycloalkyl group; Substituted or unsubstituted C6 to C60 monocyclic or polycyclic aryl group; Substituted or unsubstituted C2 to C60 monocyclic or polycyclic heteroaryl group; -SiRR'R "; -P (= O) RR '; -S (= O) (= O) R and -NRR', and L is omitted or substituted or unsubstituted as follows: Phenylene or substituted or unsubstituted biphenylylene.

페난트롤린-트리아진 화합물은 하기 표시되는 화합물들 중에서 선택될 수 있다.The phenanthroline-triazine compound can be selected from the compounds shown below.

Figure 112017111791394-pat00002
Figure 112017111791394-pat00002

TRI는  TRI

Figure 112017111791394-pat00003
,
Figure 112017111791394-pat00004
Figure 112017111791394-pat00005
중 어느 하나이며, R은 각각 독립적으로, 생략될 수 있으며, 치환 또는 치환되지 않은 할로겐, 페닐, 알킬페닐, 비페닐, 알킬비페닐, 할로페닐, 알콕시페닐, 할로알콕시페닐, 시아노페닐, 실릴페닐, 나프틸, 알킬나프틸, 할로나프틸, 시아노나프틸, 실릴나프틸, 피리딜, 알킬피리딜, 할로피리딜, 시아노피리딜, 알콕시피리딜, 실릴피리딜, 피리미딜, 할로피리미딜, 시아노피리미딜, 알콕시피리미딜, 퀴놀리닐, 이소퀴놀리닐, 퀴녹살리닐, 피라지닐, 피리미딜, 퀴나졸리닐, 나프틸리디닐, 벤조티오페닐, 벤조퓨라닐, 디벤조티오페닐, 아릴티아졸릴, 디벤조퓨라닐, 플루오레닐, 카바조일, 이미다졸릴, 카볼리닐, 페난트레닐, 터페닐, 터피리디닐, 트리페닐레닐, 플루오르안테닐 및 디아카플루오레닐 중에서 선택될 수 있다.
Figure 112017111791394-pat00003
,
Figure 112017111791394-pat00004
And
Figure 112017111791394-pat00005
Each independently, R may be omitted, substituted or unsubstituted halogen, phenyl, alkylphenyl, biphenyl, alkylbiphenyl, halophenyl, alkoxyphenyl, haloalkoxyphenyl, cyanophenyl, silyl Phenyl, naphthyl, alkylnaphthyl, halonaphthyl, cyanonaphthyl, silylnaphthyl, pyridyl, alkylpyridyl, halopyridyl, cyanopyridyl, alkoxypyridyl, silylpyridyl, pyrimidyl, halo Pyrimidyl, cyanopyrimidyl, alkoxypyrimidyl, quinolinyl, isoquinolinyl, quinoxalinyl, pyrazinyl, pyrimidyl, quinazolinyl, naphthyridinyl, benzothiophenyl, benzofuranyl, dibenzothio Among phenyl, arylthiazolyl, dibenzofuranyl, fluorenyl, carbazoyl, imidazolyl, carbolinyl, phenanthrenyl, terphenyl, terpyridinyl, triphenylenyl, fluoroantenyl and diacafluorenyl Can be selected.

본 발명의 다른 목적은, 제1전극, 제2전극 및 상기 제1전극과 상기 제2전극 사이에 위치하며 빛을 발광하는 유기물층을 포함하며, 상기 유기물층은 복수의 층으로 이루어지며, 적어도 어느 하나의 층은 페난트롤린-트리아진 화합물을 포함하는 것에 의해 달성된다.Another object of the present invention includes a first electrode, a second electrode and an organic material layer disposed between the first electrode and the second electrode to emit light, the organic material layer is composed of a plurality of layers, at least one The layer of is achieved by including a phenanthroline-triazine compound.

적어도 하나의 유기물층은 전하생성층(Charge Generation Layer; CGL)을 포함할 수 있다.At least one organic material layer may include a charge generation layer (CGL).

전하생성층(Charge Generation Layer; CGL)은 N형일 수 있다.The charge generation layer CGL may be N-type.

N형 전하생성층은, 상기 페난트롤린-트리아진 화합물에 알칼리금속 및 알칼리토금속 중 적어도 어느 하나가 도핑(doping)되어 결합되며, 상기 도핑된 알칼리금속은 Li, Na, K, Rb 및 Cs 중 적어도 어느 하나이며, 상기 알칼리토금속은 Be, Mg, Ca, Sr 및 Ba 중 적어도 어느 하나일 수 있다.In the N-type charge generation layer, at least one of an alkali metal and an alkaline earth metal is doped to the phenanthroline-triazine compound, and the doped alkali metal is selected from Li, Na, K, Rb, and Cs. At least one, and the alkaline earth metal may be at least one of Be, Mg, Ca, Sr and Ba.

유기물층은, 제1발광부, 상기 제1발광부 상에 위치하는 제2발광부 및 제1발광부와 상기 제2발광부 사이에 위치하는 제1전하생성층을 포함할 수 있다.The organic material layer may include a first light emitting part, a second light emitting part positioned on the first light emitting part, and a first charge generating layer positioned between the first light emitting part and the second light emitting part.

유기물층은, 상기 제2발광부 상에 위치하는 제3발광부, 상기 제2발광부와 상기 제3발광부 사이에 위치하는 제2전하생성층을 더 포함할 수 있다. The organic material layer may further include a third light emitting part positioned on the second light emitting part, and a second charge generating layer positioned between the second light emitting part and the third light emitting part.

본 발명에 따르면 새로운 구조의 페난트롤린-트리아진 화합물이 제공된다.According to the present invention there is provided a phenanthroline-triazine compound of novel structure.

본 발명에 따르면 N형 전하생성층과 P형 전하생성층 사이의 에너지 레벨 차이를 최소화하여 발광부에 전자 주입량을 향상시켜 구동 전압 및 효율을 향상시킬 수 있는 페난트롤린-트리아진 화합물 및 이를 포함하는 유기발광소자가 제공된다.According to the present invention, a phenanthroline-triazine compound capable of improving the driving voltage and efficiency by improving an electron injection amount in a light emitting part by minimizing an energy level difference between an N-type charge generation layer and a P-type charge generation layer, and including the same An organic light emitting device is provided.

본 발명에 따르면 N형 전하생성층이 알칼리 금속으로 도핑된 경우에도, 알칼리 금속이 P형 전하생성층으로 확산되는 현상을 최소화할 수 있는 페난트롤린-트리아진 화합물 및 이를 포함하는 유기발광소자를 제공된다.According to the present invention, even when the N-type charge generation layer is doped with an alkali metal, a phenanthroline-triazine compound capable of minimizing the diffusion of alkali metal into the P-type charge generation layer and an organic light emitting device comprising the same Is provided.

도 1은 본 발명의 일 실시예에 따른 유기발광소자의 단면도이다.
도 2는 본 발명의 일 실시예에 따른 UV 흡수 및 방출 파장을 측정한 UV-PL 곡선이다.
1 is a cross-sectional view of an organic light emitting diode according to an embodiment of the present invention.
Figure 2 is a UV-PL curve measured the UV absorption and emission wavelength according to an embodiment of the present invention.

본 발명의 이점 및 특징, 그리고 그것들을 달성하는 방법은 상세하게 후술되어 있는 실시예들을 참조하면 명확해질 것이다. 그러나 본 발명은 이하에서 개시되는 실시예들에 한정되는 것이 아니라 서로 다른 다양한 형태로 구현될 것이며, 단지 본 실시예들은 본 발명의 개시가 완전하도록 하며, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 발명의 범주를 완전하게 알려주기 위해 제공되는 것이며, 본 발명은 청구항의 범주에 의해 정의될 뿐이다. Advantages and features of the present invention and methods for achieving them will be apparent with reference to the embodiments described below in detail. However, the present invention is not limited to the embodiments disclosed below, but will be implemented in various forms, and only the present embodiments are intended to complete the disclosure of the present invention, and the general knowledge in the art to which the present invention pertains. It is provided to fully convey the scope of the invention to those skilled in the art, and the present invention is defined only by the scope of the claims.

도면에서 나타난 각 구성의 크기 및 두께는 설명의 편의를 위해 도시된 것이며, 본 발명이 도시된 구성의 크기 및 두께에 반드시 한정되는 것은 아니다.The size and thickness of each component shown in the drawings are shown for convenience of description, and the present invention is not necessarily limited to the size and thickness of the illustrated configuration.

본 발명의 여러 실시예들의 각각 특징들이 부분적으로 또는 전체적으로 서로 결합 또는 조합 가능하며, 당업자가 충분히 이해할 수 있듯이 기술적으로 다양한 연동 및 구동이 가능하며, 각 실시예들이 서로에 대하여 독립적으로 실시 가능할 수도 있고 연관 관계로 함께 실시 가능할 수도 있다.Each of the features of the various embodiments of the present invention may be combined or combined with each other in part or in whole, various technically interlocking and driving as can be understood by those skilled in the art, each of the embodiments may be implemented independently of each other It may be possible to implement the association together.

이하, 첨부된 도면을 참조하여 본 발명을 상세히 설명한다.Hereinafter, with reference to the accompanying drawings will be described in detail the present invention.

본 발명에 따른 페난트롤린-트리아진 화합물은 하기 화학식 1 또는 화학식 2로 표시된다.The phenanthroline-triazine compound according to the present invention is represented by the following general formula (1) or (2).

[화학식 1] [화학식 2][Formula 1] [Formula 2]

Figure 112017111791394-pat00006
Figure 112017111791394-pat00006

화학식 1 또는 2에서, X1, X2, X3 및 X4는 독립적으로 탄소 또는 질소이며, R1 내지 R7은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; -CN; 치환 또는 비치환된 C1 내지 C60의 직쇄 또는 분지쇄의 알킬기; 치환 또는 비치환된 C2 내지 C60의 직쇄 또는 분지쇄의 알케닐기; 치환 또는 비치환된 C2 내지 C60의 직쇄 또는 분지쇄의 알키닐기; 치환 또는 비치환된 C3 내지 C60의 단환 또는 다환의 시클로알킬기; 치환 또는 비치환된 C2 내지 C60의 단환 또는 다환의 헤테로시클로알킬기; 치환 또는 비치환된 C6 내지 C60의 단환 또는 다환의 아릴기; 치환 또는 비치환된 C2 내지 C60의 단환 또는 다환의 헤테로아릴기; -SiRR'R"; -P(=O)RR'; -S(=O)(=O)R 및 -NRR'으로 이루어진 군으로부터 선택되며, L은 생략되거나, 하기와 같은 치환 또는 비치환된 페닐렌; 또는 치환 또는 비치환된 바이페닐릴렌 중 선택될 수 있다.In Formula 1 or 2, X 1 , X 2 , X 3 and X 4 are independently carbon or nitrogen, R 1 to R 7 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Halogen group; -CN; A substituted or unsubstituted C1 to C60 straight or branched alkyl group; Substituted or unsubstituted C2 Through C60 A straight or branched chain alkenyl group; Substituted or unsubstituted C2 Through C60 A straight or branched chain alkynyl group; A substituted or unsubstituted C3 to C60 monocyclic or polycyclic cycloalkyl group; A substituted or unsubstituted C2 to C60 monocyclic or polycyclic heterocycloalkyl group; Substituted or unsubstituted C6 to C60 monocyclic or polycyclic aryl group; Substituted or unsubstituted C2 to C60 monocyclic or polycyclic heteroaryl group; -SiRR'R "; -P (= O) RR '; -S (= O) (= O) R and -NRR', and L is omitted or substituted or unsubstituted as follows: Phenylene, or substituted or unsubstituted biphenylylene.

Figure 112017111791394-pat00007
Figure 112017111791394-pat00007

본 발명에 기재된 “알킬”, “알콕시” 및 그 외 “알킬”부분을 포함하는 치환체는 직쇄 또는 분쇄 형태를 모두 포함한다.Substituents comprising the "alkyl", "alkoxy" and other "alkyl" moieties described herein include both straight and pulverized forms.

본 발명에 기재된 '아릴'은 하나의 수소 제거에 의해서 방향족 탄화수소로부터 유도된 유기 라디칼로, 각 고리에 적절하게는 4 내지 7개, 바람직하게는 5 또는 6개의 고리원자를 포함하는 단일 또는 융합고리계를 포함하며, 다수개의 아릴이 단일결합으로 연결되어 있는 형태까지 포함한다.'Aryl' described in the present invention is an organic radical derived from an aromatic hydrocarbon by one hydrogen removal, and is a single or fused ring containing 4 to 7, preferably 5 or 6 ring atoms in each ring as appropriate. It includes a system, including a form in which a plurality of aryl is connected by a single bond.

구체적인 예로 페닐, 나프틸, 비페닐, 안트릴, 인데닐(indenyl), 플루오레닐, 페난트릴, 트리페닐레닐, 피렌일, 페릴렌일, 크라이세닐, 나프타세닐, 플루오란텐일 등을 포함하지만, 이에 한정되지 않는다. 나프틸은 1-나프틸 및 2-나프틸일 수 있으며, 안트릴은 1-안트릴, 2-안트릴 및 9-안트릴일 수 있고, 플루오레닐은 1-플루오레닐, 2-플루오레닐, 3-플루오레닐, 4-플루오레닐 및 9-플루오레닐을 모두 포함한다. 본 발명에 기재된 '헤테로아릴'은 방향족 고리 골격 원자로서 B, N, O, S, P(=O), Si 및 P로부터 선택되는 1 내지 4개의 헤테로원자를 포함하고, 나머지 방향족 고리 골격 원자가 탄소인 아릴 그룹을 의미하는 것으로, 5 내지 6원 단환 헤테로아릴, 및 하나 이상의 벤젠환과 축합된 다환식 헤테로아릴이며, 부분적으로 포화될 수 있다. Specific examples include phenyl, naphthyl, biphenyl, anthryl, indenyl, fluorenyl, phenanthryl, triphenylenyl, pyrenyl, peryleneyl, chrysenyl, naphthasenyl, fluoranthenyl, and the like. It is not limited to this. Naphthyl can be 1-naphthyl and 2-naphthyl, anthryl can be 1-anthryl, 2-anthryl and 9-anthryl, and fluorenyl is 1-fluorenyl, 2-fluor Nil, 3-fluorenyl, 4-fluorenyl and 9-fluorenyl. 'Heteroaryl' described in the present invention includes 1 to 4 heteroatoms selected from B, N, O, S, P (= O), Si and P as aromatic ring skeleton atoms, and the remaining aromatic ring skeleton atoms are carbon. Meaning an aryl group which is 5 to 6 membered monocyclic heteroaryl, and polycyclic heteroaryl condensed with one or more benzene rings, which may be partially saturated.

또한, 본 발명에서의 '헤테로아릴'은 하나 이상의 헤테로아릴이 단일결합으로 연결된 형태도 포함한다. 상기 헤테로아릴기는 고리 내 헤테로원자가 산화되거나 사원화되어, 예를 들어 N-옥사이드 또는 4차 염을 형성하는 2가 아릴 그룹을 포함한다. 구체적인 예로 퓨릴, 티오펜일, 피롤릴, 이미다졸릴, 피라졸릴, 티아졸릴, 티아디아졸릴, 이소티아졸릴, 이속사졸릴, 옥사졸릴, 옥사디아졸릴, 트리아진일, 테트라진일, 트리아졸릴, 테트라졸릴, 퓨라잔일, 피리딜, 피라진일, 피리미딘일, 피리다진일 등의 단환 헤테로아릴, 벤조퓨란일, 벤조티오펜일, 이소벤조퓨란일, 벤조이미다졸릴, 벤조티아졸릴, 벤조이소티아졸릴, 벤조이속사졸릴, 벤조옥사졸릴, 이소인돌릴, 인돌릴, 인다졸릴, 벤조티아디아졸릴, 퀴놀릴, 이소퀴놀릴, 신놀리닐, 퀴나졸리닐, 퀴녹살리닐, 카바졸릴, 페난트리딘일, 벤조디옥솔릴 등의 다환식 헤테로아릴 및 이들의 상응하는 N-옥사이드(예를 들어, 피리딜 N-옥사이드, 퀴놀릴 N-옥사이드), 이들의 4차 염 등을 포함하지만, 이에 한정되지 않는다.In addition, the "heteroaryl" in the present invention also includes a form in which one or more heteroaryl is connected by a single bond. Such heteroaryl groups include divalent aryl groups in which heteroatoms in the ring are oxidized or quaternized to form, for example, N-oxides or quaternary salts. Specific examples include furyl, thiophenyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, thiadiazolyl, isothiazolyl, isoxazolyl, oxazolyl, oxadiazolyl, triazinyl, tetrazinyl, triazolyl, tetra Monocyclic heteroaryl such as zolyl, furazanyl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, benzofuranyl, benzothiophenyl, isobenzofuranyl, benzoimidazolyl, benzothiazolyl, benzoisothia Zolyl, Benzoisoxazolyl, Benzooxazolyl, Isoindoleyl, Indolyl, Indazolyl, Benzothiadiazolyl, Quinolyl, Isoquinolyl, Cinolinyl, Quinazolinyl, Quinoxalinyl, Carbazolyl, Phenantridinyl Polycyclic heteroaryls such as benzodioxolyl and the like, and their corresponding N-oxides (eg, pyridyl N-oxides, quinolyl N-oxides), quaternary salts thereof, and the like. .

또한, 본 발명에 기재되어 있는 '치환 또는 비치환'이라는 기재는 상기 R1 내지 R7의 치환기가 각각 독립적으로 중수소, 할로겐, 할로겐이 치환 또는 비치환된 (C1-C30)알킬, (C6-C30)아릴, (C6-C30)아릴이 치환 또는 비치환된 (C3-C30)헤테로아릴, 5원 내지 7원의 헤테로시클로알킬, 방향족고리가 하나이상 융합된 5원 내지 7원의 헤테로시클로알킬, (C3-C30)시클로알킬, 방향족 고리가 하나이상 융합된 (C6-C30)시클로알킬, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 아다만틸, (C7-C30)바이시클로알킬, (C2-C30)알케닐, (C2-C30)알키닐, 시아노, 카바졸릴, NR21R22, BR23R24, PR25R26, P(=O)R27R28 [R21 내지 R28은 서로 독립적으로 치환 또는 비치환된 (C1-C30)알킬, 치환 또는 비치환된 (C6-C30)아릴 또는 치환 또는 비치환된 (C3-C30)헤테로아릴이다.], (C6-C30)아르(C1-C30)알킬, (C1-C30)알킬(C6-C30)아릴, (C1-C30)알킬옥시, (C1-C30)알킬티오, (C6-C30)아릴옥시, (C6-C30)아릴티오, (C1-C30)알콕시카보닐, (C1-C30)알킬카보닐, (C6-C30)아릴카보닐, (C6-C30)아릴옥시카보닐, (C1-C30)알콕시카보닐옥시, (C1-C30)알킬카보닐옥시, (C6-C30)아릴카보닐옥시, (C6-C30)아릴옥시카보닐옥시, 카르복실, 나이트로 또는 하이드록시로 이루어진 군으로부터 선택되는 하나 이상으로 더 치환되거나, 서로 인접한 치환체가 연결되어 고리를 형성하는 것을 의미한다.In addition, the description of "substituted or unsubstituted" described in the present invention is that each of the substituents of R 1 to R 7 is independently (C1-C30) alkyl, (C6-C30) alkyl substituted or unsubstituted deuterium, halogen, halogen C30) aryl, (C6-C30) aryl substituted or unsubstituted (C3-C30) heteroaryl, 5- to 7-membered heterocycloalkyl, 5- to 7-membered heterocycloalkyl fused with one or more aromatic rings , (C3-C30) cycloalkyl, (C6-C30) cycloalkyl fused with one or more aromatic rings, tri (C1-C30) alkylsilyl, di (C1-C30) alkyl (C6-C30) arylsilyl, tri ( C6-C30) arylsilyl, adamantyl, (C7-C30) bicycloalkyl, (C2-C30) alkenyl, (C2-C30) alkynyl, cyano, carbazolyl, NR 21 R 22 , BR 23 R 24 , PR 25 R 26 , P (= O) R 27 R 28 [R 21 to R 28 are independently of each other substituted or unsubstituted (C1-C30) alkyl, substituted or unsubstituted (C6-C30) aryl or Substituted or unsubstituted (C3-C30) heteroaryl.], (C6-C3) 0) ar (C1-C30) alkyl, (C1-C30) alkyl (C6-C30) aryl, (C1-C30) alkyloxy, (C1-C30) alkylthio, (C6-C30) aryloxy, (C6- C30) arylthio, (C1-C30) alkoxycarbonyl, (C1-C30) alkylcarbonyl, (C6-C30) arylcarbonyl, (C6-C30) aryloxycarbonyl, (C1-C30) alkoxycarbonyl At least one selected from the group consisting of oxy, (C1-C30) alkylcarbonyloxy, (C6-C30) arylcarbonyloxy, (C6-C30) aryloxycarbonyloxy, carboxyl, nitro or hydroxy More substituted or adjacent substituents are connected to form a ring.

본 발명에 따른 페난트롤린-트리아진 화합물은 하기 표시되는 화합물들 중에서 선택되는 어느 하나일 수 있다.The phenanthroline-triazine compound according to the present invention may be any one selected from the compounds shown below.

Figure 112017111791394-pat00008
Figure 112017111791394-pat00008

여기에서, TRI는 Here, TRI is

Figure 112017111791394-pat00009
,
Figure 112017111791394-pat00010
Figure 112017111791394-pat00011
중 어느 하나일 수 있다.
Figure 112017111791394-pat00009
,
Figure 112017111791394-pat00010
And
Figure 112017111791394-pat00011
It may be any one of.

R은 각각 독립적으로, 생략될 수 있으며, 치환 또는 치환되지 않은 할로겐, 페닐, 알킬페닐, 비페닐, 알킬비페닐, 할로페닐, 알콕시페닐, 할로알콕시페닐, 시아노페닐, 실릴페닐, 나프틸, 알킬나프틸, 할로나프틸, 시아노나프틸, 실릴나프틸, 피리딜, 알킬피리딜, 할로피리딜, 시아노피리딜, 알콕시피리딜, 실릴피리딜, 피리미딜, 할로피리미딜, 시아노피리미딜, 알콕시피리미딜, 퀴놀리닐, 이소퀴놀리닐, 퀴녹살리닐, 피라지닐, 피리미딜, 퀴나졸리닐, 나프틸리디닐, 벤조티오페닐, 벤조퓨라닐, 디벤조티오페닐, 아릴티아졸릴, 디벤조퓨라닐, 플루오레닐, 카바조일, 이미다졸릴, 카볼리닐, 페난트레닐, 터페닐, 터피리디닐, 트리페닐레닐, 플루오르안테닐 및 디아카플루오레닐 중에서 선택될 수 있다.Each R, independently, may be omitted, substituted or unsubstituted halogen, phenyl, alkylphenyl, biphenyl, alkylbiphenyl, halophenyl, alkoxyphenyl, haloalkoxyphenyl, cyanophenyl, silylphenyl, naphthyl, Alkyl naphthyl, halonaphthyl, cyanonaphthyl, silylnaphthyl, pyridyl, alkylpyridyl, halopyridyl, cyanopyridyl, alkoxypyridyl, silylpyridyl, pyrimidyl, halopyrimidyl, cyano Pyrimidyl, alkoxypyrimidyl, quinolinyl, isoquinolinyl, quinoxalinyl, pyrazinyl, pyrimidyl, quinazolinyl, naphthyridinyl, benzothiophenyl, benzofuranyl, dibenzothiophenyl, arylthiazolyl , Dibenzofuranyl, fluorenyl, carbazoyl, imidazolyl, carbolinyl, phenanthrenyl, terphenyl, terpyridinyl, triphenylenyl, fluoroantenyl and diacafluorenyl.

또한 본 발명에 따른 페난트롤린-트리아진 화합물은 하기로 표시되는 화합물일 수 있다.In addition, the phenanthroline-triazine compound according to the present invention may be a compound represented by the following.

Figure 112017111791394-pat00012
Figure 112017111791394-pat00012

Figure 112017111791394-pat00013
Figure 112017111791394-pat00013

Figure 112017111791394-pat00014
Figure 112017111791394-pat00014

Figure 112017111791394-pat00015
Figure 112017111791394-pat00015

Figure 112017111791394-pat00016
Figure 112017111791394-pat00016

Figure 112017111791394-pat00017
Figure 112017111791394-pat00017

Figure 112017111791394-pat00018
Figure 112017111791394-pat00018

전술한 화학식 1 또는 화학식 2로 표시되는 화합물은 하기와 같이 모식화하여 나타낼 수 있다.The compound represented by Chemical Formula 1 or Chemical Formula 2 described above may be schematically represented as follows.

Figure 112017111791394-pat00019
Figure 112017111791394-pat00019

고효율의 유기전계발광 소자를 구현하기 위하여 적절한 밴드갭(band gap)과 에너지 레벨(energy level)을 갖는 물질이 개발되어야 한다. 적절한 에너지 레벨을 갖는 물질들은 인접층으로의 전하주입을 용이하게 함으로써 구동전압을 낮추고 수명을 증가시킨다. 또한, 사용된 유기 물질은 높은 유리전이온도(glass transition temperature, Tg)와 분해온도(decomposition temperature, Td)를 가짐으로써 열적으로 안정하여 소자의 지속적이고 안정된 구동이 가능하다. In order to implement a high efficiency organic electroluminescent device, a material having an appropriate band gap and energy level must be developed. Materials with appropriate energy levels lower drive voltage and increase lifetime by facilitating charge injection into adjacent layers. In addition, the organic material used is thermally stable by having a high glass transition temperature (T g ) and decomposition temperature (T d ), thereby enabling continuous and stable operation of the device.

본 발명에 따른 화합물에서는 전하 이동도가 높고, 열적으로 매우 안정한 트리아진 코어를 포함한다. 이러한, 트리아진 코어에 연결된 페난트롤린은 전하생성층에 도핑되는 금속과 결합하여 우수한 N형 전하생성층 특성을 나타낼 수 있다. 이로 인해 고효율의 유기발광소자의 구현이 가능하다.The compounds according to the invention comprise triazine cores which have a high charge mobility and are very thermally stable. The phenanthroline connected to the triazine core may combine with the metal doped in the charge generation layer to exhibit excellent N-type charge generation layer properties. As a result, a high efficiency organic light emitting diode can be realized.

보다 자세하게는, 페난트롤린 코어는 전자가 상대적으로 풍부한 sp2 혼성 오비탈의 질소(N)를 포함하여, 이 질소가 N형 전하생성층의 도펀트인 알칼리금속 또는 알칼리 토금속과 결합(binding)하여 갭 스테이트(gap state)를 형성하고, 형성된 갭 스테이트에 의해, N형 전하생성층에서 전자수송층으로 전자의 전달을 원활하게 할 수 있다. 높은 전하수송능력과 높은 전자친화도 및 열 안정성을 갖고 있는 트리아진 코어와 결합함으로써 전하 수송 능력을 극대화하여 효율을 높일 수 있다.More specifically, the phenanthroline core contains nitrogen (N) in the sp 2 hybrid orbital, which is relatively rich in electrons, which binds to and gaps with alkali or alkaline earth metals, which are dopants of the N-type charge generation layer. A gap state is formed and the formed gap state facilitates the transfer of electrons from the N-type charge generation layer to the electron transport layer. By combining with a triazine core with high charge transport capacity, high electron affinity and thermal stability, the efficiency of charge transport can be maximized.

링커(linker)는 전하 이동도(carrier mobility)를 조절한다. 컨쥬게이션(conjugation) 조절을 통해 트리아진과 페난트롤린을 연결해주는 통로 역할을 하고, HOMO(highest occupied molecular orbital)와 LUMO(lowest unoccupied molecular orbital) 값을 조절한다. The linker regulates carrier mobility. It acts as a pathway to connect triazine and phenanthroline through regulation of conjugation, and it is possible to adjust the highest occupied molecular orbital (HOMO) and lower unoccupied molecular orbital (LUMO) values. Adjust

특히 링커(linker) 부분에 N형 또는 P형의 특성을 갖는 모이어티를 부가함으로써 미세한 밴드갭 튜닝이 가능해진다. 본 발명에 따른 화합물은, 페난트롤린과 트리아진의 강력한 전자끌게 성질을 완화할 수 있도록 헤테로 아릴을 갖는 전자끌개 모이어티를 부가함으로써, 전자의 밀집을 분산시켜주고 화학적 안정성을 높임으로 유기발광소자의 수명을 개선할 수 있는 효과가 있다.In particular, by adding a moiety having an N-type or P-type characteristic to a linker portion, fine bandgap tuning is possible. The compound according to the present invention, by adding an electron withdrawal moiety having a heteroaryl to relieve the strong electron attracting properties of phenanthroline and triazine, to disperse the electron density and to increase the chemical stability of the organic light emitting device It has the effect of improving the life of the.

스택(stack)구조에서, 전하생성층의 재료는 블루층의 빛을 흡수하지 않아야 한다. 본 발명에 따른 페난트롤린-트리아진 화합물은 블루층의 빛을 흡수하지 않아 효율적인 전하생성층 및 이를 포함하는 고효율의 유기발광소자의 구현이 가능하다.In a stack structure, the material of the charge generating layer should not absorb light of the blue layer. The phenanthroline-triazine compound according to the present invention does not absorb light of the blue layer, and thus an efficient charge generation layer and a high efficiency organic light emitting device including the same can be realized.

본 발명에 따른 화합물은 열적 안정성이 우수한데, 유리전이온도는 128℃ 이상이며, 융용 온도가 296℃ 이상일 수 있다. 이로 인해 고효율의 유기발광소자의 구현이 가능하다.The compound according to the present invention is excellent in thermal stability, the glass transition temperature is 128 ℃ or more, the melting temperature may be 296 ℃ or more. As a result, a high efficiency organic light emitting diode can be realized.

도 1은 본 발명의 일 실시예에 따른 유기발광소자의 단면도이다.1 is a cross-sectional view of an organic light emitting diode according to an embodiment of the present invention.

도 1을 참조하면, 유기발광소자(1)는 탠덤형 구조로서 제1전극(양극, 110), 제2전극(음극, 120), 제1발광부(210), 제2발광부(220), 제3발광부(230), 제1전하생성층(240) 및 제2전하생성층(250)을 포함한다.Referring to FIG. 1, the organic light emitting diode 1 has a tandem structure and includes a first electrode (anode 110), a second electrode (cathode 120), a first light emitter 210, and a second light emitter 220. The third light emitting unit 230 may include a first charge generation layer 240 and a second charge generation layer 250.

제1발광부(210), 제2발광부(220), 제3발광부(230), 제1전하생성층(240) 및 제2(250)은 유기물층으로서 제1전극(110)과 제2전극(120) 사이에 위치하며, 제1전하생성층(240)은 제1발광부(210)와 제2발광부(220) 사이에 위치하고, 제2전하생성층(250)은 제2발광부(220)와 제3발광부(230)사이에 위치한다.The first light emitter 210, the second light emitter 220, the third light emitter 230, the first charge generation layer 240, and the second 250 are organic layers and the first electrode 110 and the second light emitter. Located between the electrodes 120, the first charge generating layer 240 is located between the first light emitting portion 210 and the second light emitting portion 220, the second charge generating layer 250 is the second light emitting portion Located between the 220 and the third light emitting unit 230.

제1발광부(210)는 정공주입층(211), 제1정공수송층(212), 제1발광층(213), 제1전자수송층(214)으로 이루어져 있으며, 제2발광부(220)는 제2정공수송층(221), 제2발광층(222) 및 제2전자수송층(223)으로 이루어져 있고, 제3발광부(230)는 제3정공수송층(231), 제3발광층(232), 제3전자수송층(233) 및 전자주입층(234)으로 이루어져 있다.The first light emitting unit 210 includes a hole injection layer 211, a first hole transport layer 212, a first light emitting layer 213, and a first electron transport layer 214, and the second light emitting unit 220 is formed of a first light emitting layer 220. The second hole transport layer 221, the second light emitting layer 222 and the second electron transport layer 223, the third light emitting unit 230 is a third hole transport layer 231, the third light emitting layer 232, the third The electron transport layer 233 and the electron injection layer 234.

제1 전하생성층(240)은 N형 전하생성층(241)과 P형 전하생성층(242)으로 이루어져 있으며, 제2 전하생성층(250)은 N형 전하생성층(251)과 P형 전하생성층(252)으로 이루어져 있다. 각 N형 전하생성층(241, 251)은 알칼리 금속 및 알칼리토금속 중 적어도 어느 하나가 도핑(doping)되어 결합되며, 도핑된 알칼리금속은 Li, Na, K, Rb 및 Cs 중 적어도 어느 하나, 도핑된 알칼리토금속은 Be, Mg, Ca, Sr 및 Ba 중 적어도 어느 하나일 수 있다.The first charge generation layer 240 is composed of an N-type charge generation layer 241 and a P-type charge generation layer 242, and the second charge generation layer 250 is an N-type charge generation layer 251 and a P-type. The charge generation layer 252. Each of the N-type charge generation layers 241 and 251 is doped with at least one of an alkali metal and an alkaline earth metal, and the doped alkali metal is doped with at least one of Li, Na, K, Rb, and Cs. The alkaline earth metal may be at least one of Be, Mg, Ca, Sr, and Ba.

본 발명에 따른 페난트롤린-트리아진은 제1전자수송층(214), 제2전자수송층(223), 제3전자수송층(233), 전자주입층(234), 제1전하생성층(240) 및/또는 제2전하생성층(250)에 포함되어 사용될 수 있으며, 특히 N형 전하생성층(241, 251) 및/또는 전자수송층(214, 223, 233)에 사용될 수 있다.The phenanthroline-triazine according to the present invention includes a first electron transport layer 214, a second electron transport layer 223, a third electron transport layer 233, an electron injection layer 234, and a first charge generation layer 240. And / or included in the second charge generation layer 250, and in particular, may be used in the N-type charge generation layers 241 and 251 and / or the electron transport layers 214, 223 and 233.

설명한 유기발광소자(1)는 다양하게 변형가능하다. 일부 유기층은 생략되거나 추가될 수 있으며, 탠덤형태가 아닐 수 있으며, 2개 또는 4개 이상의 발광층을 가지는 탠덤형태일 수도 있다. 또한, 유기발광소자(1)는 전자수송과 전자주입을 동시에 하는 층을 포함하는 유기층을 포함할 수 있으며, 이러한 경우에도 본 발명에 따른 페난트롤린-트리아진 화합물이 사용될 수 있다.The organic light emitting device 1 described above can be variously modified. Some organic layers may be omitted or added, may not be tandem, or may be tandem with two or more light emitting layers. In addition, the organic light emitting device 1 may include an organic layer including a layer for simultaneously performing electron transport and electron injection. In this case, the phenanthroline-triazine compound according to the present invention may be used.

이하에서는 화합물 1-1, 1-5, 1-9, 1-24, 1-25, 1-36 및 유기발광소자의 실시예 1 내지 6과 비교예를 설명한다. 다만, 하기에 기재된 제조예 및 실시예들은 본 발명을 구체적으로 예시하거나 설명하기 위한 것일 뿐이며, 이하에 기재된 제조예 및 실시예에 의해 본 발명을 제한하여 해석되어서는 안 된다.Hereinafter, Examples 1 to 6 and Comparative Examples of Compounds 1-1, 1-5, 1-9, 1-24, 1-25, 1-36, and an organic light emitting diode will be described. However, the production examples and examples described below are merely for illustrating or explaining the present invention in detail, and should not be construed as limiting the present invention by the production examples and examples described below.

[[ 제조예Production Example ]]

1. 중간체 (1): 2,4-1.Intermediate (1): 2,4- diphenyldiphenyl -6-(3-(4,4,5,5--6- (3- (4,4,5,5- tetramethyltetramethyl -1,3,2-dioxaborolan-2-yl)phenyl)-1,3,5-triazine 의 제조Preparation of -1,3,2-dioxaborolan-2-yl) phenyl) -1,3,5-triazine

Figure 112017111791394-pat00020
Figure 112017111791394-pat00020

2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (20g, 51mmol) 및 Bis(pinacolato)diboron (27g, 61mmol), [1,1'-Bis(diphenyl phosphino)ferrocene]dichloropalladium(Ⅱ) (1.9g, 2.5mmol), Potassium acetate (15.2g, 155mmol)에 Dioxane 260mL을 투입했다. 17시간 동안 환류 교반 후 상온까지 식혔다. 반응액을 실리카겔과 셀라이트에 감압 여과하여 여과액을 얻은 후 농축했다. 그리고 다이클로로메테인과 메탄올로 재결정하여 중간체 (1)을 21.5g (수득률 96%)을 얻었다.2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (20g, 51mmol) and Bis (pinacolato) diboron (27g, 61mmol), [1,1'-Bis (diphenyl phosphino) ferrocene ] Dioxane 260mL was added to dichloropalladium (II) (1.9g, 2.5mmol) and Potassium acetate (15.2g, 155mmol). After stirring for 17 hours at reflux, the mixture was cooled to room temperature. The reaction solution was filtered under reduced pressure through silica gel and celite to obtain a filtrate and concentrated. And recrystallized with dichloromethane and methanol, 21.5g (yield 96%) of intermediates (1) were obtained.

2. 중간체 (2): 1-(3,5-2. Intermediate (2): 1- (3,5- dibromophenyldibromophenyl )) ethanone의of ethanone 제조 Produce

Figure 112017111791394-pat00021
Figure 112017111791394-pat00021

1,3,5-tribromobenzene (20g, 64mmol)을 Ether 500mL에 녹인 후 -78℃까지 냉각 시켰다. 2.5M n-Butyllithim 39.6mL을 천천히 첨가하였다. 이 후 -78℃에서 2시간 동안 교반 후 Ether 50mL에 녹인 N,N-dimethylacetamide 6.5mL을 천천히 첨가했다. 상온에서 17시간 동안 교반했다. HCl(10%) 350mL을 반응액에 넣어 반응을 종결했다. 다이클로로메테인과 물을 이용하여 유기층을 중성화 시켜 준 후 물층을 제거하고, 잔류 물층은 Magnesium sulfate를 이용하여 제거했다. 유기층은 실리카겔과 셀라이트에 감압여과하였고, 얻어진 여과액을 농축 후 에탄올로 재결정하여 중간체 (2)를 7.5g (수득률 43%)을 얻었다.1,3,5-tribromobenzene (20g, 64mmol) was dissolved in 500mL of Ether and cooled to -78 ℃. 39.6 mL 2.5 M n-Butyllithim was added slowly. After stirring at -78 ° C for 2 hours, 6.5 mL of N, N-dimethylacetamide dissolved in 50 mL of Ether was added slowly. Stir at room temperature for 17 hours. 350 mL of HCl (10%) was added to the reaction solution to terminate the reaction. After neutralizing the organic layer using dichloromethane and water, the water layer was removed, and the remaining water layer was removed using Magnesium sulfate. The organic layer was filtered under reduced pressure with silica gel and celite, and the filtrate was concentrated and recrystallized with ethanol to obtain 7.5 g (yield 43%) of intermediate (2).

3. 화합물 1-1의 3. Compound 1-1 제조예Production Example

화합물 1-1로 표시된 2-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(phenanthren-9-yl)phenyl)-1,10-phenanthroline을 아래와 같은 반응들을 이용해 제조하였다.2- (3- (4,6-diphenyl-1,3,5-triazin-2-yl) -5- (phenanthren-9-yl) phenyl) -1,10-phenanthroline represented by compound 1-1 is shown below. Prepared using the same reactions.

Figure 112017111791394-pat00022
Figure 112017111791394-pat00022

2-(3,5-dibromophenyl)-4,6-diphenyl-1,3,5-triazine (16.5g, 35mmol) 및 phenanthren-9-ylboronic acid (5g, 24mmol), Tetrakis(triphenylphosphine)palladium(0) (1.4g, 1.1mmol), Potassium carbonate (9.8g, 71mmol)를 톨루엔 150mL와 에탄올 150mL, 물 150mL에 넣고 약 5시간 동안 환류 교반했다. 생성된 고체를 필터하여 얻은 후, 물 세척 2회와 메탄올 세척 1회를 한 후 건조시켰다. 컬럼 분리 (전개액 다이클로로메테인 100%)를 통해 불순물을 제거 한 후 2-(3-bromo-5-(phenanthren-9-yl)phenyl)-4,6-diphenyl-1,3,5-triazine을 4g (수득률 30%)을 얻었다. 여기에 Bis(pinacolato)diboron (2.2g, 8.6mmol), [1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium(II) (0.26g, 0.36mmol), Potassium acetate (2.1g, 22mmol)에 Dioxane 100m를 투입하였다. 17시간 동안 환류 교반 후 상온까지 식혔다. 반응액을 실리카겔과 셀라이트에 감압여과하여 여과액을 얻었다. 이 여과액에 2-bromo-1,10-phenanthroline (1.5g, 5.8mmol), Tetrakis(triphenylphosphine)palladium(0) (0.3g, 0.26mmol), Potassium carbonate (2.4g, 52mmol)를 넣고 약 14시간 동안 환류 교반했다. 상온으로 식힌 후 다이클로로메테인과 물을 이용하여 유기층을 중성화 시켜 준 후 물층을 제거하였고, 잔류 물층은 Magnesium sulfate를 이용하여 제거했다. 유기층은 실리카겔과 셀라이트에 감압여과하고, 실리카겔 흡착 컬럼(전개액 헥산:다이클로로메테인=9:1 → 다이클로로메테인 100%)진행하여 얻어진 크루드를 다이클로로메테인과 헥산으로 세척하여 화합물 1-1을 2g을 얻었다.2- (3,5-dibromophenyl) -4,6-diphenyl-1,3,5-triazine (16.5g, 35mmol) and phenanthren-9-ylboronic acid (5g, 24mmol), Tetrakis (triphenylphosphine) palladium (0) (1.4 g, 1.1 mmol) and Potassium carbonate (9.8 g, 71 mmol) were added to 150 mL of toluene, 150 mL of ethanol, and 150 mL of water, followed by stirring under reflux for about 5 hours. The resulting solids were obtained by filtration, dried twice after washing with water and once with methanol. 2- (3-bromo-5- (phenanthren-9-yl) phenyl) -4,6-diphenyl-1,3,5- after removing impurities through column separation (100% dichloromethane solution) 4g (30% yield) of triazine were obtained. Dioxane 100m in Bis (pinacolato) diboron (2.2g, 8.6mmol), [1,1′-Bis (diphenylphosphino) ferrocene] dichloropalladium (II) (0.26g, 0.36mmol), Potassium acetate (2.1g, 22mmol) Was added. After stirring for 17 hours at reflux, the mixture was cooled to room temperature. The reaction solution was filtered under reduced pressure with silica gel and celite to obtain a filtrate. 2-bromo-1,10-phenanthroline (1.5g, 5.8mmol), Tetrakis (triphenylphosphine) palladium (0) (0.3g, 0.26mmol) and Potassium carbonate (2.4g, 52mmol) were added to the filtrate for about 14 hours. Stirred under reflux. After cooling to room temperature, the organic layer was neutralized using dichloromethane and water, and then the water layer was removed, and the remaining water layer was removed using Magnesium sulfate. The organic layer was filtered under reduced pressure with silica gel and celite, and the crude obtained by performing silica gel adsorption column (eluent hexane: dichloromethane = 9: 1 → dichloromethane 100%) was washed with dichloromethane and hexane. 2g of compound 1-1 was obtained.

4. 화합물 1-5의 4. Of Compound 1-5 제조예Production Example

화합물 1-5로 표시된 2-(3-(dibenzo[b,d]furan-4-yl)-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-1,10-phenanthroline을 아래와 같은 반응들을 이용해 제조하였다.2- (3- (dibenzo [b, d] furan-4-yl) -5- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) -1 represented by compound 1-5 , 10-phenanthroline was prepared using the following reactions.

Figure 112017111791394-pat00023
Figure 112017111791394-pat00023

2-(3,5-dibromophenyl)-4,6-diphenyl-1,3,5-triazine (16.5g, 35mmol) 및 dibenzo[b,d]furan-4-ylboronic acid (5g, 24mmol), Tetrakis(triphenylphosphine)palladium(0) (1.4g, 1.1mmol), Potassium carbonate (9.8g, 71mmol)를 톨루엔 120mL와 에탄올 120mL, 물 120mL에 넣고 약 3시간 동안 환류 교반했다. 생성된 고체를 필터하여 얻은 후, 물 세척 3회와 메탄올 세척 2회를 한 후 건조 시켰다. 컬럼 분리 (전개액 헥산 100% → 다이클로로메테인 100%)를 통해 불순물을 제거 한 후 2-(3-bromo-5-(dibenzo[b,d]furan-4-yl)phenyl)-4,6-diphenyl-1,3,5-triazine을 4g (수득률 30%)을 얻었다. 여기에 Bis(pinacolato)diboron (2.2g, 8.6mmol), [1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium(II) (0.26g, 0.36mmol), Potassium acetate (2.1g, 22mmol)에 Dioxane 100m를 투입하였다. 17시간 동안 환류 교반 후 상온까지 식혔다. 반응액을 실리카겔과 셀라이트에 감압여과하여 여과액을 얻었다. 이 여과액에 2-bromo-1,10-phenanthroline (1.5g, 5.8mmol), Tetrakis(triphenylphosphine)palladium(0) (0.3g, 0.26mmol), Potassium carbonate (2.4g, 17mmol)를 넣고 약 14시간 동안 환류 교반했다. 상온으로 식힌 후 실리카겔 흡착 컬럼(전개액 헥산:다이클로로메테인=9:1 → 다이클로로메테인 100%)진행하여 얻어진 크루드를 다이클로로메테인과 헥산으로 세척하여 화합물 1-5을 1.5g (수득률 50%)을 얻었다.2- (3,5-dibromophenyl) -4,6-diphenyl-1,3,5-triazine (16.5g, 35mmol) and dibenzo [b, d] furan-4-ylboronic acid (5g, 24mmol), Tetrakis ( Triphenylphosphine) palladium (0) (1.4 g, 1.1 mmol) and Potassium carbonate (9.8 g, 71 mmol) were added to 120 mL of toluene, 120 mL of ethanol, and 120 mL of water, followed by stirring under reflux for about 3 hours. The resulting solid was obtained by filtration, dried three times after washing with water and two times with methanol. After removing impurities through column separation (100% of eluent hexane to 100% dichloromethane), 2- (3-bromo-5- (dibenzo [b, d] furan-4-yl) phenyl) -4, 4g (yield 30%) of 6-diphenyl-1,3,5-triazine was obtained. Dioxane 100m in Bis (pinacolato) diboron (2.2g, 8.6mmol), [1,1′-Bis (diphenylphosphino) ferrocene] dichloropalladium (II) (0.26g, 0.36mmol), Potassium acetate (2.1g, 22mmol) Was added. After stirring for 17 hours at reflux, the mixture was cooled to room temperature. The reaction solution was filtered under reduced pressure with silica gel and celite to obtain a filtrate. 2-bromo-1,10-phenanthroline (1.5g, 5.8mmol), Tetrakis (triphenylphosphine) palladium (0) (0.3g, 0.26mmol) and Potassium carbonate (2.4g, 17mmol) were added to the filtrate for about 14 hours. Stirred under reflux. After cooling to room temperature, proceed with a silica gel adsorption column (developing solution hexane: dichloromethane = 9: 1 → dichloromethane 100%) to wash the crude obtained with dichloromethane and hexane to obtain 1.5 g of compound 1-5. (50% yield) was obtained.

5. 화합물 1-9의 5. Of Compound 1-9 제조예Production Example

화합물 1-9로 표시된 2-(5-(4,6-diphenyl-1,3,5-triazin-2-yl)-4'-(pyrimidin-2-yl)-[1,1'-biphenyl]-3-yl)-1,10-phenanthroline을 아래와 같은 반응들을 이용해 제조하였다.2- (5- (4,6-diphenyl-1,3,5-triazin-2-yl) -4 '-(pyrimidin-2-yl)-[1,1'-biphenyl] represented by compound 1-9 -3-yl) -1,10-phenanthroline was prepared using the following reactions.

Figure 112017111791394-pat00024
Figure 112017111791394-pat00024

2-(3,5-dibromophenyl)-4,6-diphenyl-1,3,5-triazine (19.8g, 42mmol) 및 (4-(pyrimidin-2-yl)phenyl)boronic acid (7g, 35mmol), Tetrakis(triphenylphosphine)palladium(0) (2.0g, 1.8mmol), Potassium carbonate (14.5g, 105mmol)를 톨루엔 175mL와 에탄올 175mL, 물 175mL에 넣고 약 3시간 동안 환류 교반했다. 생성된 고체를 필터하여 얻은 후, 물 세척 3회와 메탄올 세척 2회를 한 후 건조 시켰다. 컬럼 분리 (전개액 헥산 100% → 다이클로로메테인 100%)를 통해 불순물을 제거 한 후 2-(5-bromo-4'-(pyrimidin-2-yl)-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine을 10g (수득률 53%)을 얻었다. 여기에 Bis(pinacolato)diboron (5.6g, 22mmol), [1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium(II) (0.67g, 0.92mmol), Potassium acetate (5.4g, 55mmol)에 Dioxane 100m를 투입하였다. 17시간 동안 환류 교반 후 상온까지 식혔다. 반응액을 실리카겔과 셀라이트에 감압여과하여 여과액을 얻었다. 이 여과액에 2-bromo-1,10-phenanthroline (4.4g, 17mmol), Tetrakis(triphenylphosphine)palladium(0) (1g, 0.85mmol), Potassium carbonate (7g, 51mmol)를 넣고 약 17시간 동안 환류 교반했다. 상온으로 식힌 후 실리카겔 흡착 컬럼(전개액 헥산:다이클로로메테인=9:1 → 다이클로로메테인 100%)진행하여 얻어진 크루드를 다이클로로메테인과 헥산으로 재결정하여 화합물 1-9을 5g (수득률 50%)을 얻었다.2- (3,5-dibromophenyl) -4,6-diphenyl-1,3,5-triazine (19.8g, 42mmol) and (4- (pyrimidin-2-yl) phenyl) boronic acid (7g, 35mmol), Tetrakis (triphenylphosphine) palladium (0) (2.0 g, 1.8 mmol) and Potassium carbonate (14.5 g, 105 mmol) were added to 175 mL of toluene, 175 mL of ethanol, and 175 mL of water, followed by stirring under reflux for about 3 hours. The resulting solid was obtained by filtration, dried three times after washing with water and two times with methanol. After removing impurities through column separation (100% of eluent hexane → 100% dichloromethane), 2- (5-bromo-4 '-(pyrimidin-2-yl)-[1,1'-biphenyl]- 10 g (yield 53%) of 3-yl) -4,6-diphenyl-1,3,5-triazine was obtained. Dioxane 100m in Bis (pinacolato) diboron (5.6g, 22mmol), [1,1′-Bis (diphenylphosphino) ferrocene] dichloropalladium (II) (0.67g, 0.92mmol), Potassium acetate (5.4g, 55mmol) Input. After stirring for 17 hours at reflux, the mixture was cooled to room temperature. The reaction solution was filtered under reduced pressure with silica gel and celite to obtain a filtrate. 2-bromo-1,10-phenanthroline (4.4g, 17mmol), Tetrakis (triphenylphosphine) palladium (0) (1g, 0.85mmol) and Potassium carbonate (7g, 51mmol) were added to the filtrate and stirred under reflux for about 17 hours. did. After cooling to room temperature, a crude gel obtained by running a silica gel adsorption column (developing solution hexane: dichloromethane = 9: 1 to dichloromethane 100%) was recrystallized from dichloromethane and hexane to obtain 5 g of compound 1-9 ( Yield 50%).

6. 화합물 1-24의 6. Of Compound 1-24 제조예Production Example

화합물 1-24로 표시된 2-(2-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)pyridin-4-yl)-1,10-phenanthroline을 아래와 같은 반응들을 이용해 제조하였다.2- (2- (3- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) pyridin-4-yl) -1,10-phenanthroline represented by compound 1-24 is shown below. Prepared using the reactions.

Figure 112017111791394-pat00025
Figure 112017111791394-pat00025

7. 화합물 1-25의 7. Of Compound 1-25 제조예Production Example

화합물 1-25로 표시된 2-(6-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)pyridin-2-yl)-1,10-phenanthroline을 아래와 같은 반응들을 이용해 제조하였다.2- (6- (3- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) pyridin-2-yl) -1,10-phenanthroline represented by compound 1-25 is shown below. Prepared using the reactions.

Figure 112017111791394-pat00026
Figure 112017111791394-pat00026

8. 화합물 1-36의 제조예8. Preparation of Compound 1-36

화합물 1-36로 표시된 2-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)-[1,1':3',1''-terphenyl]-5'-yl)-1,10-phenanthroline을 아래와 같은 반응들을 이용해 제조하였다.2- (3- (4,6-diphenyl-1,3,5-triazin-2-yl)-[1,1 ': 3', 1 ''-terphenyl] -5'- represented by compound 1-36 yl) -1,10-phenanthroline was prepared using the following reactions.

Figure 112017111791394-pat00027
Figure 112017111791394-pat00027

합성한 화합물들의 NMR 데이터는 다음과 같다.NMR data of the synthesized compounds are as follows.

화합물compound 1H NMR(CDCl3)1 H NMR (CDCl 3) MSMS 화합물 1-1

Figure 112017111791394-pat00028
Compound 1-1
Figure 112017111791394-pat00028
1H δ
1H NMR (500 MHz, CDCll3) δ 9.69 (1H, s), 9.17 (1H, s), 9.04 (1H, s), 8.86-8.81 (7H, m), 8.43-8.39 (2H, d), 8.26-8.24 (1H, m), 8.05-8.03 (2H, m), 7.97(1H, s), 7.86-7.82 (2H, d), 7.74-7.55 (11H, m)
1H δ
1 H NMR (500 MHz, CDCll 3) δ 9.69 (1H, s), 9.17 (1H, s), 9.04 (1H, s), 8.86-8.81 (7H, m), 8.43-8.39 (2H, d), 8.26- 8.24 (1H, m), 8.05-8.03 (2H, m), 7.97 (1H, s), 7.86-7.82 (2H, d), 7.74-7.55 (11H, m)
510.2
510.2
화합물 1-5
Figure 112017111791394-pat00029
Compound 1-5
Figure 112017111791394-pat00029
1H δ
1H NMR (500 MHz, CDCl3) δ 9.60 (1H, s), 9.53-9.53 (1H, m), 9.25-9.24 (1H, d), 9.17 (1H, m), 8.88-8.86 (4H, m), 8.44-8.37 (2H, dd), 8.28-8.26 (1H, m), 8.64-8.03 (2H, m), 7.97-7.95 (1H, m), 7.88-7.81 (2H, dd), 7.71-7.70 (1H, m), 7.67-7.53 (9H, m), 7.41-7.38 (1H, m)
1H δ
1 H NMR (500 MHz, CDCl 3) δ 9.60 (1H, s), 9.53-9.53 (1H, m), 9.25-9.24 (1H, d), 9.17 (1H, m), 8.88-8.86 (4H, m), 8.44-8.37 (2H, dd), 8.28-8.26 (1H, m), 8.64-8.03 (2H, m), 7.97-7.95 (1H, m), 7.88-7.81 (2H, dd), 7.71-7.70 (1H , m), 7.67-7.53 (9H, m), 7.41-7.38 (1H, m)
654.2654.2
화합물 1-9
Figure 112017111791394-pat00030
Compound 1-9
Figure 112017111791394-pat00030
1H δ
1H NMR (500 MHz, CDCl3) δ 9.56-9.55 (1H, t), 9.27-9.26 (1H, q), 9.19-9.18 (1H, t), 9.01-9.00 (1H, t), 8.88-8.85 (6H, m), 8.66-8.64 (2H, m), 8.47-8.45 (1H, d), 8.39-8.37 (1H, d), 8.30-8.28 (1H, q), 8.08-8.06 (2H, m), 7.90-7.88 (1H, d), 7.85-7.83 (1H, d), 7.69-7.67 (1H, q), 7.365-7.60 (6H, m), 7.14-7.22 (1H, t)
1H δ
1 H NMR (500 MHz, CDCl 3) δ 9.56-9.55 (1H, t), 9.27-9.26 (1H, q), 9.19-9.18 (1H, t), 9.01-9.00 (1H, t), 8.88-8.85 (6H , m), 8.66-8.64 (2H, m), 8.47-8.45 (1H, d), 8.39-8.37 (1H, d), 8.30-8.28 (1H, q), 8.08-8.06 (2H, m), 7.90 -7.88 (1H, d), 7.85-7.83 (1H, d), 7.69-7.67 (1H, q), 7.365-7.60 (6H, m), 7.14-7.22 (1H, t)
642.2642.2
화합물 1-24
Figure 112017111791394-pat00031
Compound 1-24
Figure 112017111791394-pat00031
1H δ
1H NMR (500 MHz, CDCl3) δ 9.58 (1H, s), 9.49-9.48 (1H, m), 9.29-9.28 (1H, m), 8.99-8.97 (1H, m), 8.89-8.87 (1H, d), 8.85-8.83 (4H, m), 8.42-8.40 (2H, m), 8.31-8.29 (1H, d), 8.24-8.22 (1H, d), 8.15-8.13 (1H, d), 7.89-7.83 (2H, dd), 7.76-7.73 (1H, t), 7.70-7.68 (1H, m), 7.64-7.60 (6H, m)
1H δ
1 H NMR (500 MHz, CDCl 3) δ 9.58 (1H, s), 9.49-9.48 (1H, m), 9.29-9.28 (1H, m), 8.99-8.97 (1H, m), 8.89-8.87 (1H, d ), 8.85-8.83 (4H, m), 8.42-8.40 (2H, m), 8.31-8.29 (1H, d), 8.24-8.22 (1H, d), 8.15-8.13 (1H, d), 7.89-7.83 (2H, dd), 7.76-7.73 (1H, t), 7.70-7.68 (1H, m), 7.64-7.60 (6H, m)
565.2565.2
화합물 1-25
Figure 112017111791394-pat00032
Compound 1-25
Figure 112017111791394-pat00032
1H δ
1H NMR (500 MHz, CDCl3) δ 9.21 (1H, m), 9.11 (1H, s), 8.82-8.79 (5H, m), 8.55-8.54 (2H, d), 8.39-8.37 (1H, d), 8.04-8.03 (2H, m), 7.86-7.80 (4H, m), 7.65-7.43 (9H, m)
1H δ
1 H NMR (500 MHz, CDCl 3) δ 9.21 (1H, m), 9.11 (1H, s), 8.82-8.79 (5H, m), 8.55-8.54 (2H, d), 8.39-8.37 (1H, d), 8.04-8.03 (2H, m), 7.86-7.80 (4H, m), 7.65-7.43 (9H, m)
565.2565.2
화합물 1-36
Figure 112017111791394-pat00033
Compound 1-36
Figure 112017111791394-pat00033
1H δ
1H NMR (500 MHz, CDCl3) δ 9.21-9.20 (1H, m), 9.11 (1H, s), 8.82-8.79 (5H, m), 8.55-8.54 (2H, d), 8.39-8.37 (1H, d), 8.27-8.23 (2H, m), 8.04-8.03 (2H, t), 7.86-7.80 (4H, m), 7.73-7.70 (1H, t), 7.65-7.51 (9H, m), 7.44-7.43 (1H, m)
1H δ
1 H NMR (500 MHz, CDCl 3) δ 9.21-9.20 (1H, m), 9.11 (1H, s), 8.82-8.79 (5H, m), 8.55-8.54 (2H, d), 8.39-8.37 (1H, d ), 8.27-8.23 (2H, m), 8.04-8.03 (2H, t), 7.86-7.80 (4H, m), 7.73-7.70 (1H, t), 7.65-7.51 (9H, m), 7.44-7.43 (1H, m)
640.2640.2

[UV 흡수 파장 스펙트럼 측정][UV absorption wavelength spectrum measurement]

본 발명에 따른 페난트롤린-트리아진 화합물 1-1의 UV/Vis 흡수 및 방출 파장을 측정하였다.The UV / Vis absorption and emission wavelengths of the phenanthroline-triazine compound 1-1 according to the present invention were measured.

측정장비는 형광분광광도계(fluorescence spectrophotometer)로서 Varian사의 Cary Eclipse를 사용하였으며 시료는 메틸렌클로라이드(methylene chloride)에 0.1 - 1 ppm의 농도로 녹여서 측정하였다.  Varian's Cary Eclipse was used as a fluorescence spectrophotometer, and the sample was measured by dissolving in methylene chloride at a concentration of 0.1-1 ppm.

도 2의 UV-PL 곡선은 본 발명에 따른 페난트롤린-트리아진 화합물 1-1의 UV 흡수 및 방출 파장측정 결과를 나타낸 것이다. 도 2에 도시된 바와 같이 도시된 바와 같이 화합물 1-1의 UV 흡수 파장은 400nm 이내이며, 블루층에서 나오는 빛을 흡수하지 않음을 알 수 있다. UV-PL curve of Figure 2 shows the results of UV absorption and emission wavelength measurement of phenanthroline-triazine compound 1-1 according to the present invention. As shown in FIG. 2, it can be seen that the UV absorption wavelength of Compound 1-1 is within 400 nm and does not absorb light emitted from the blue layer.

[유리전이 온도 측정][Glass Transition Temperature Measurement]

제조예 1 내지 6 및 전하생성층에 주로 사용되는 Bphen의 유리전이온도와 융용온도를 측정하여 이하의 표 2에 나타내었다. The glass transition temperature and melting temperature of Bphen mainly used in Preparation Examples 1 to 6 and the charge generation layer were measured and shown in Table 2 below.

구분division 물질matter Tg(oC)Tg ( o C) Tm(oC)Tm ( o C) 비교예Comparative example BPhenBPhen 6464 220220 제조예 1Preparation Example 1 화합물 1-1Compound 1-1 168.16 168.16 318.30 318.30 제조예 2Preparation Example 2 화합물 1-5Compound 1-5 136.19136.19 314.59314.59 제조예 3Preparation Example 3 화합물 1-9Compound 1-9 144.76 144.76 291.24 291.24 제조예 4Preparation Example 4 화합물 1-24Compound 1-24 128.15 128.15 296.65 296.65 제조예 5Preparation Example 5 화합물 1-25Compound 1-25 129.23 129.23 314.90 314.90 제조예 6Preparation Example 6 화합물 1-36Compound 1-36 132.91 132.91 --

표 2에 나타난 바와 같이, 제조예 1 내지 제조예 6은 비교예에 비해 유리전이온도 및 용융온도가 훨씬 높은 것을 알 수 있다. 따라서, 본 발명에 따른 화합물은 열적 안정성이 뛰어난 것을 확인할 수 있다.As shown in Table 2, Preparation Examples 1 to 6 it can be seen that the glass transition temperature and the melting temperature is much higher than the comparative example. Therefore, it can be confirmed that the compound according to the present invention has excellent thermal stability.

이하에는 전하생성층에 각각 비교예로 Bphen 및 실시예로 화합물 1-30을 사용하여 유기발광소자를 제조하여 실험하였다.Hereinafter, an organic light emitting diode was manufactured and manufactured by using Bphen as a comparative example and compound 1-30 as an example in the charge generation layer.

[유기발광소자의 제조][Production of Organic Light Emitting Device]

1.One. 비교예Comparative example 1 One

발광면적이 2mm × 2mm크기가 되도록 ITO 기판을 패터닝한 후, 이소프로필 알코올과 UV 오존으로 각각 세정을 실시하였다. 이후, ITO기판을 진공 증착 장치의 기판 홀더에 장착하고 진공도가 1×10-7 torr가 되도록 압력을 설정하였다.After the ITO substrate was patterned so that the light emitting area was 2 mm × 2 mm in size, washing was performed with isopropyl alcohol and UV ozone, respectively. Thereafter, the ITO substrate was mounted on the substrate holder of the vacuum deposition apparatus, and the pressure was set such that the vacuum degree was 1 × 10 −7 torr.

먼저, HAT-CN 화합물을 진공 증착하여 5nm 두께로 형성하였다. 이 화합물은 정공수송층으로 작용한다. 이 위에 정공수송층으로 NPB 물질을 35nm 두께로 형성하였다.First, a HAT-CN compound was vacuum deposited to form a 5 nm thick. This compound acts as a hole transport layer. An NPB material was formed to a thickness of 35 nm as a hole transport layer thereon.

이후 CPB 물질을 호스트로, Ir 화합물을 도판트로 약 10% 질량비가 되도록 30nm의 두께로 공증착하여 노란색 발광층을 형성하였다. Afterwards, a yellow light-emitting layer was formed by co-depositing a CPB material with a host and an Ir compound with a dopant at a thickness of 30 nm to have a mass ratio of about 10%.

이 발광층위에 TmPyPB 화합물을 25nm 두께로 전자수송층을 형성하였다. 이후 BPhen물질에 Li물질을 2% 질량비가 되도록 10nm 두께로 공증착하여 전하생성층을 형성하였다. 이후, Al을 100nm 두께로 증착시켜 음극을 형성하여 유기발광소자를 제작하였다.An electron transport layer was formed on the light emitting layer with a TmPyPB compound having a thickness of 25 nm. Afterwards, a charge generation layer was formed by co-depositing the Li material on the BPhen material to a thickness of 10 nm to have a 2% mass ratio. Thereafter, Al was deposited to a thickness of 100 nm to form a cathode to fabricate an organic light emitting device.

Figure 112017111791394-pat00034
Figure 112017111791394-pat00035
Figure 112017111791394-pat00036
Figure 112017111791394-pat00034
Figure 112017111791394-pat00035
Figure 112017111791394-pat00036

Figure 112017111791394-pat00037
Figure 112017111791394-pat00038
Figure 112017111791394-pat00037
Figure 112017111791394-pat00038

2.2. 실시예EXAMPLE 1 One

위에 전술한 비교예 1과 동일하게 구성하되, 전하생성층 물질만 화합물 1-1로 바꾸어 유기발광소자를 제작하였다.An organic light emitting device was manufactured in the same manner as in Comparative Example 1, except that only the charge generation layer material was changed to compound 1-1.

PIN OLED의 경우 OLED 구조 내에 전하 수송층에 전기적 도핑을 통하여 저전압 고효율 구동을 실현한다. P 도핑 층에는 정공수송물질에 전자가 희박한 유기물질이나 금속 산화물을 도핑하고, N 도핑 층에는 전자수송물질에 일함수가 낮은 리튬이나 세슘 등의 알칼리 금속을 도핑하게 된다. 도핑된 층은 구동되는 동안 유기물질의 표면 저항을 줄여서 인접 층으로부터 전하 주입을 용이하게 한다. 도핑된 양극층 위에 버퍼층을 도입하여 에너지 밴딩에 의한 저전압 구현, 전하이동도가 높은 소재를 이용한 저전압 구동기술 등이 알려져 있으며 형광과 인광 소재를 적층구조로 제작하여 높은 효율을 얻고 있다. In the case of PIN OLEDs, low-voltage high-efficiency driving is realized through electrical doping of the charge transport layer in the OLED structure. The P doping layer is doped with an electron-lean organic material or metal oxide in the hole transport material, and the N doping layer is doped with an alkali metal such as lithium or cesium having a low work function in the electron transport material. The doped layer reduces the surface resistance of the organic material during operation to facilitate charge injection from adjacent layers. The introduction of a buffer layer on the doped anode layer realizes low voltage by energy banding and a low voltage driving technique using a material having high charge mobility.

이하에는 실시예 1 및 비교예 1의 유기발광소자의 전류 밀도, 구동 전압, 전류 효율, 및 외부양자효율을 측정하여 이하의 표 3에 나타냈다.Hereinafter, the current density, driving voltage, current efficiency, and external quantum efficiency of the organic light emitting diodes of Example 1 and Comparative Example 1 were measured and shown in Table 3 below.

물질matter J(mA/cm2)J (mA / cm 2 ) VV cd/Acd / A lm/Wlm / W QEQE 비교예 1Comparative Example 1 BPhenBPhen 1010 4.54.5 56.556.5 39.439.4 19.119.1 실시예 1Example 1 1-11-1 1010 3.93.9 59.259.2 47.747.7 2020

본 발명에 따른 실시예 1의 구동 전압은 비교예 1에 비해 낮아지는 반면 실시예 1의 전류효율과 외부 양자 효율은 비교예에 비해 높아진 것을 확인할 수 있다.It can be seen that the driving voltage of Example 1 according to the present invention is lower than that of Comparative Example 1 while the current efficiency and external quantum efficiency of Example 1 are higher than that of Comparative Example.

3. 3. 비교예Comparative example 2 2

발광면적이 2mm × 2mm크기가 되도록 ITO 기판을 패터닝한 후, 이소프로필 알코올과 UV 오존으로 각각 세정을 실시하였다. 이후, ITO기판을 진공 증착 장치의 기판 홀더에 장착하고 진공도가 1×10-7 torr가 되도록 압력을 잡았다.After the ITO substrate was patterned so that the light emitting area was 2 mm × 2 mm in size, washing was performed with isopropyl alcohol and UV ozone, respectively. Thereafter, the ITO substrate was mounted on the substrate holder of the vacuum deposition apparatus and pressure was applied such that the vacuum degree was 1 × 10 −7 torr.

먼저, HAT-CN 화합물을 진공 증착하여 5nm 두께로 형성하였다. 이 화합물은 제 1 정공주입층으로 작용한다. 이 위에 제 1 정공수송층으로 NPB 물질을 35nm 두께로 형성하였다.First, a HAT-CN compound was vacuum deposited to form a 5 nm thick. This compound acts as the first hole injection layer. An NPB material was formed on the first hole transport layer to a thickness of 35 nm.

이후 CPB 물질을 호스트로, Ir 화합물을 도판트로 약 10% 질량비가 되도록 30nm의 두께로 공증착하여 노란색 제 1 발광층을 형성하였다. Thereafter, the CPB material was used as a host, and the Ir compound was co-deposited at a thickness of 30 nm to form a dopant of about 10% by mass to form a yellow first emission layer.

이 발광층위에 TmPyPB 화합물을 25nm 두께로 전자수송층을 형성하였다. 이후 BPhen물질에 Li물질을 2% 질량비가 되도록 10nm 두께로 공증착하여 N형 전하생성층을 형성하였다. 이후, P형 전하생성층으로 HAT-CN 화합물을 5nm 두께로 진공 증착하였다. 이물질은 제 2 정공주입층으로도 활용된다. 이 위에 제 2 정공수송층으로 NPB 물질을 35nm 두께로 형성하였다.An electron transport layer was formed on the light emitting layer with a TmPyPB compound having a thickness of 25 nm. Afterwards, an N-type charge generation layer was formed by co-depositing a Li material on the BPhen material at a thickness of 10 nm to have a 2% mass ratio. Thereafter, a HAT-CN compound was vacuum deposited to a thickness of 5 nm with a P-type charge generation layer. Foreign substances are also used as the second hole injection layer. The NPB material was formed to a thickness of 35 nm as the second hole transport layer.

이후 CPB 물질을 호스트로, Ir 화합물을 도판트로 약 10% 질량비가 되도록 30nm의 두께로 공증착하여 노란색 제 2 발광층을 형성하였다. 이 발광층위에 TmPyPB 화합물을 25nm 두께로 전하생성층을 형성하였다. 이후 LiF 물질을 전자주입층으로 1nm 두께로 진공 증착하였다. 마지막으로 Al을 100nm 두께로 증착시켜 음극을 형성하여 유기 EL 소자를 제작하였다.Afterwards, a second light emitting layer was formed by co-depositing a CPB material with a host and an Ir compound with a dopant to a thickness of about 30 nm at a thickness of 30 nm. A charge generating layer was formed on the light emitting layer with a TmPyPB compound having a thickness of 25 nm. The LiF material was then vacuum deposited to a thickness of 1 nm into the electron injection layer. Finally, Al was deposited to a thickness of 100 nm to form a cathode to fabricate an organic EL device.

4. 4. 실시예EXAMPLE 2 2

위에 전술한 비교예와 동일하게 구성하되, N형 전하생성층의 유기물질만 화합물 1-5로 바꾸어 유기발광소자를 제작하였다.The organic light emitting device was manufactured by the same method as the comparative example described above, but replacing only the organic material of the N-type charge generation layer with compound 1-5.

5. 5. 실시예EXAMPLE 3 3

위에 전술한 비교예와 동일하게 구성하되, N형 전하생성층의 유기물질만 화합물 1-9로 바꾸어 유기발광소자를 제작하였다.The organic light emitting device was fabricated in the same manner as in the comparative example above, but replacing only the organic material of the N-type charge generation layer with compound 1-9.

6. 6. 실시예EXAMPLE 4 4

위에 전술한 비교예와 동일하게 구성하되, N형 전하생성층의 유기물질만 화합물 1-24로 바꾸어 유기발광소자를 제작하였다.The organic light emitting device was manufactured by the same method as the comparative example described above, but replacing only the organic material of the N-type charge generation layer with compound 1-24.

7. 7. 실시예EXAMPLE 5 5

위에 전술한 비교예와 동일하게 구성하되, N형 전하생성층의 유기물질만 화합물 1-25로 바꾸어 유기발광소자를 제작하였다.The organic light emitting device was fabricated in the same manner as the comparative example described above, except that only the organic material of the N-type charge generation layer was changed to compound 1-25.

8. 8. 실시예EXAMPLE 6 6

위에 전술한 비교예와 동일하게 구성하되, N형 전하생성층의 유기물질만 화합물 1-36로 바꾸어 유기발광소자를 제작하였다.The organic light emitting device was manufactured by the same method as the comparative example described above, but replacing only the organic material of the N-type charge generation layer with compound 1-36.

Tandem 구조는 도핑된 정공수송층과 전자수송층을 포함하는 EL 단위를 수직으로 적층한 구조로, 적층한 수에 비례하여 전류발광효율이 증가한다. 이때 CGL (change generation layer)층은 투명한 PN 접합의 개념이며, 단위 PIN OLED 발광부를 복수의 층으로 쌓아 놓은 개념으로 이해하면 된다. 따라서 단일 층의 PIN OLED 실시예로도 스택구조의 효율과 전압을 예측할 수 있으며, 2층 구조의 실시예로도 3층 구조의 효율과 전압을 예측할 수 있다.The tandem structure is a structure in which EL units including a doped hole transport layer and an electron transport layer are vertically stacked, and current luminous efficiency increases in proportion to the number of stacked layers. In this case, the CGL (change generation layer) layer is a concept of a transparent PN junction, and can be understood as a concept in which a unit PIN OLED light emitting unit is stacked in a plurality of layers. Therefore, the efficiency and voltage of the stack structure can be predicted by the single-layer PIN OLED embodiment, and the efficiency and voltage of the three-layer structure can be predicted by the two-layer structure.

실시예 2 내지 6 및 비교예 2의 유기발광소자의 전류 밀도, 구동 전압, 전류 효율, 및 외부양자효율을 측정하여 표 4에 나타내었다.The current density, driving voltage, current efficiency, and external quantum efficiency of the organic light emitting diodes of Examples 2 to 6 and Comparative Example 2 were measured and shown in Table 4.

구분division 물질matter 구동전류J(mA/cm2)Drive current J (mA / cm2) 구동전압(Voltage)Drive Voltage 전류효율
(cd/A)
Current efficiency
(cd / A)
발광 효율(lm/W)Luminous Efficiency (lm / W) EQE(%)EQE (%)
비교예 2Comparative Example 2 BPhenBPhen 1010 9.49.4 107.8107.8 36.036.0 3535 실시예 2Example 2 1-51-5 1010 8.718.71 123123 44.444.4 39.139.1 실시예 3Example 3 1-91-9 1010 8.618.61 126.5126.5 46.246.2 40.040.0 실시예 4Example 4 1-241-24 1010 8.78.7 125.5125.5 45.345.3 39.939.9 실시예 5Example 5 1-251-25 1010 8.448.44 121.8121.8 45.345.3 37.537.5 실시예 6Example 6 1-361-36 1010 8.668.66 129.5129.5 47.047.0 40.040.0

표 4에 기재된 바와 같이, 실시예 2 내지 실시예 6은, 비교예 2와 비교했을 ?, 구동전압(V)은 낮아지는 반면, 전류 효율(cd/A), 및 외부양자효율(QE)에 있어서, 뛰어난 것을 알 수 있다. As shown in Table 4, in Examples 2 to 6, the driving voltage (V) was lowered compared to Comparative Example 2, while the current efficiency (cd / A) and external quantum efficiency (QE) were lowered. It can be seen that it is excellent.

따라서 본 발명에 따른 페난트롤린-트리아진 화합물을 포함하는 유기발광소자는 종래 화합물을 포함하는 유기발광소자에 비해 수명이 개선되고, 효율이 향상될 수 있음을 알 수 있다.Therefore, it can be seen that the organic light emitting device including the phenanthroline-triazine compound according to the present invention has improved lifespan and improved efficiency compared to the organic light emitting device including the conventional compound.

본 발명은 반드시 이러한 실시예로 국한되는 것은 아니고, 본 발명의 기술사상을 벗어나지 않는 범위 내에서 다양하게 변형 실시될 수 있다. 따라서, 본 발명에 개시된 실시예들은 본 발명의 기술 사상을 한정하기 위한 것이 아니라 설명하기 위한 것이고, 이러한 실시예에 의하여 본 발명의 기술 사상의 범위가 한정되는 것은 아니다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 본 발명의 보호 범위는 아래의 청구범위에 의하여 해석되어야 하며, 그와 동등한 범위 내에 있는 모든 기술 사상은 본 발명의 권리범위에 포함되는 것으로 해석되어야 할 것이다.The present invention is not necessarily limited to these embodiments, and various modifications can be made without departing from the spirit of the present invention. Therefore, the embodiments disclosed in the present invention are not intended to limit the technical idea of the present invention but to describe the present invention, and the scope of the technical idea of the present invention is not limited by these embodiments. Therefore, it should be understood that the embodiments described above are exemplary in all respects and not restrictive. The protection scope of the present invention should be interpreted by the following claims, and all technical ideas within the equivalent scope should be interpreted as being included in the scope of the present invention.

Claims (9)

하기 표시되는 화합물 중 선택되는 어느 하나인 것을 특징으로 하는 페난트롤린(phenanthroline)-트리아진(triazine) 화합물.
Figure 112019060518183-pat00053
A phenanthroline (triazine) compound, characterized in that any one selected from the compounds shown below.
Figure 112019060518183-pat00053
삭제delete 삭제delete 제1전극;
제2전극; 및
상기 제1전극과 상기 제2전극 사이에 위치하며 빛을 발광하는 유기물층을 포함하며,
상기 유기물층은 복수의 층으로 이루어지며, 적어도 어느 하나의 층은 제1항 에 따른 페난트롤린-트리아진 화합물을 포함하는 유기발광소자.
A first electrode;
Second electrode; And
An organic material layer disposed between the first electrode and the second electrode and emitting light;
The organic layer is composed of a plurality of layers, at least one layer of the organic light emitting device comprising the phenanthroline-triazine compound according to claim 1.
제4항에 있어서,
상기 적어도 하나의 유기물층은 전하생성층(Charge Generation Layer; CGL)을 포함하는 것을 특징으로 하는 유기발광소자.
The method of claim 4, wherein
The at least one organic material layer is an organic light emitting device, characterized in that it comprises a charge generation layer (CGL).
제5항에 있어서,
상기 전하생성층(Charge Generation Layer; CGL)은 N형인 것을 특징으로 하는 유기발광소자.
The method of claim 5,
The charge generation layer (CGL) is an organic light emitting device, characterized in that the N-type.
제 6항에 있어서,
상기 N형 전하생성층은,
상기 페난트롤린-트리아진 화합물에 알칼리금속 및 알칼리토금속 중 적어도 어느 하나가 도핑(doping)되어 결합되며,
상기 도핑된 알칼리금속은 Li, Na, K, Rb 및 Cs 중 적어도 어느 하나이며,
상기 알칼리토금속은 Be, Mg, Ca, Sr 및 Ba 중 적어도 어느 하나인 것을 특징으로 하는 유기발광소자.
The method of claim 6,
The N-type charge generation layer,
At least one of an alkali metal and an alkaline earth metal is doped to the phenanthroline-triazine compound,
The doped alkali metal is at least one of Li, Na, K, Rb and Cs,
The alkaline earth metal is at least any one of Be, Mg, Ca, Sr and Ba.
제4항에 있어서,
상기 유기물층은,
제1발광부;
상기 제1발광부 상에 위치하는 제2발광부;및
상기 제1발광부와 상기 제2발광부 사이에 위치하는 제1전하생성층;
을 포함하는 것을 특징으로 하는 유기발광 소자.
The method of claim 4, wherein
The organic material layer,
A first light emitting unit;
A second light emitting unit positioned on the first light emitting unit; and
A first charge generation layer positioned between the first light emitting unit and the second light emitting unit;
An organic light emitting device comprising a.
제8항에 있어서,
상기 유기물층은,
상기 제2발광부 상에 위치하는 제3발광부;
상기 제2발광부와 상기 제3발광부 사이에 위치하는 제2전하생성층;
을 더 포함하는 것을 특징으로 하는 유기발광 소자.
The method of claim 8,
The organic material layer,
A third light emitting unit positioned on the second light emitting unit;
A second charge generation layer positioned between the second light emitting part and the third light emitting part;
An organic light emitting device characterized in that it further comprises.
KR1020170149589A 2017-11-10 2017-11-10 Phenanthroline-triazine compound and organic light emitting diode comprising the same KR102034192B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020170149589A KR102034192B1 (en) 2017-11-10 2017-11-10 Phenanthroline-triazine compound and organic light emitting diode comprising the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170149589A KR102034192B1 (en) 2017-11-10 2017-11-10 Phenanthroline-triazine compound and organic light emitting diode comprising the same

Publications (2)

Publication Number Publication Date
KR20190053562A KR20190053562A (en) 2019-05-20
KR102034192B1 true KR102034192B1 (en) 2019-10-18

Family

ID=66678696

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170149589A KR102034192B1 (en) 2017-11-10 2017-11-10 Phenanthroline-triazine compound and organic light emitting diode comprising the same

Country Status (1)

Country Link
KR (1) KR102034192B1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102559589B1 (en) * 2018-07-06 2023-07-25 솔루스첨단소재 주식회사 Organic compound and organic electroluminescent device including the same
JP2020094031A (en) * 2018-10-22 2020-06-18 東ソー株式会社 Cyclic azine compound, material for organic electroluminescent element, electron transport material for organic electroluminescent element, and organic electroluminescent element
WO2020085319A1 (en) * 2018-10-22 2020-04-30 東ソー株式会社 Cyclic azine compound, material for organic electroluminescent elements, electron transport material for organic electroluminescent elements, and organic electroluminescent element
WO2020111225A1 (en) * 2018-11-30 2020-06-04 東ソー株式会社 Triazine compound, material for organic electroluminescent element, and organic electroluminescent element
JP7469753B2 (en) * 2018-11-30 2024-04-17 東ソー株式会社 Triazine compound, material for organic electroluminescence device, and organic electroluminescence device
KR20200077951A (en) * 2018-12-21 2020-07-01 두산솔루스 주식회사 Organic compounds and organic electro luminescence device comprising the same
CN112409276A (en) * 2019-08-20 2021-02-26 北京鼎材科技有限公司 Compound and application thereof
EP3805206A1 (en) 2019-10-08 2021-04-14 Novaled GmbH Compound and an organic semiconducting layer, an organic electronic device, a display device and a lighting device comprising the same
KR20210127291A (en) 2020-04-13 2021-10-22 삼성디스플레이 주식회사 Heterocyclic compound and organic light emitting device including the same
KR20210138832A (en) * 2020-05-12 2021-11-22 삼성디스플레이 주식회사 Organic electroluminescence device and compound for organic electroluminescence device
CN112028879B (en) * 2020-09-29 2023-07-21 烟台京师材料基因组工程研究院 Electron transport material, organic electroluminescent device and display device
WO2022181197A1 (en) * 2021-02-24 2022-09-01 東レ株式会社 Organic el element material, organic el element, display device, and illumination device
CN113816898A (en) * 2021-03-29 2021-12-21 烟台显华化工科技有限公司 Compound, electron transport material, organic electroluminescent device and display device
CN115925690A (en) * 2021-09-23 2023-04-07 烟台显华化工科技有限公司 Compound, electron transport material and organic electroluminescent device
WO2024018915A1 (en) * 2022-07-20 2024-01-25 東レ株式会社 Compound, light-emitting element, display device, and lighting device
WO2024043018A1 (en) * 2022-08-22 2024-02-29 東レ株式会社 Organic el element, display device, and lighting device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102869266B (en) 2010-03-12 2015-07-15 阿尔拉食品公司 A reticulate dairy based product
KR102195540B1 (en) * 2014-04-25 2020-12-29 덕산네오룩스 주식회사 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
KR102432080B1 (en) * 2014-12-08 2022-08-16 엘지디스플레이 주식회사 Organic Light Emitting Display Device

Also Published As

Publication number Publication date
KR20190053562A (en) 2019-05-20

Similar Documents

Publication Publication Date Title
KR102034192B1 (en) Phenanthroline-triazine compound and organic light emitting diode comprising the same
CN108699058B (en) Hetero-fused phenylquinazolines and their use in electronic devices
KR102040226B1 (en) Organic light emitting device
JP6195828B2 (en) Material for organic electroluminescence device and organic electroluminescence device using the same
CN105745200B (en) Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
EP2674429B1 (en) Biscarbazole derivative and organic electroluminescent element using same
KR102232993B1 (en) Organic electroluminescence element
CN106232591B (en) Electron transport material and organic electroluminescent device comprising the same
JP6270735B2 (en) Aromatic amine derivative and organic electroluminescence device
KR20140037814A (en) Biscarbazole derivative and organic electroluminescent element using same
KR20140108637A (en) Material for organic electroluminescent element and organic electroluminescent element
US20120187392A1 (en) Imidazopyridine derivatives and organic electroluminescent elements containing same
KR101882592B1 (en) Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device
KR20190020683A (en) Specially substituted benzofuro- and benzothienoquinolines for organic light emitting diodes
KR20180097573A (en) Novel compounds, materials for organic electroluminescent devices and organic electroluminescent devices
WO2017056053A1 (en) Benzimidazolo[1,2-a]benzimidazole carrying benzimidazolo[1,2-a]benzimidazolyl groups, carbazolyl groups, benzofurane groups or benzothiophene groups for organic light emitting diodes
KR102148239B1 (en) benzo(b)fluoranthene compounds and organic light emitting diode comprising the same
WO2014051004A1 (en) Material for organic electroluminescent elements, and organic electroluminescent element
KR20190053354A (en) Phenanthroline-anthracene compound and organic light emitting diode comprising the same
US20180319813A1 (en) Benzimidazole fused heteroaryls
KR20200064423A (en) Pyrene compound and organic light emitting element comprising the same
WO2014054263A1 (en) Material for organic electroluminescent element, and organic electroluminescent element produced using same
KR102341609B1 (en) Organic electroluminescence element and electronic device
WO2014050093A1 (en) Material for organic electroluminescent element, and organic electroluminescent element produced using same
KR20190118821A (en) Condensed cyclic compound and organic light-emitting device including the same

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant